(Q37057996)

18 August 2017

1 reference

title

Gut hormones as potential new targets for appetite regulation and the treatment of obesity (English)

1 reference

18 August 2017

0 references

1 reference

Benjamin C T Field

1

1 reference

18 August 2017

Alison M Wren

series ordinal

2

1 reference

18 August 2017

Dunstan Cooke

series ordinal

3

1 reference

18 August 2017

Stephen R Bloom

series ordinal

4

1 reference

18 August 2017

publication date

1 January 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

68

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

147-163

1 reference

Weight gain as a risk factor for clinical diabetes mellitus in women

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868020-00002

Human pancreatic polypeptide: studies of fasting and postprandial plasma concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868020-00002

Pancreatic polypeptide: a possible role in the regulation of food intake in the mouse. Hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868020-00002

Human distribution and release of a putative new gut hormone, peptide YY

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868020-00002

Peptide YY(3-36) inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868020-00002

Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868020-00002

Repeated ICV administration of oxyntomodulin causes a greater reduction in body weight gain than in pair-fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868020-00002

Daily CCK injection enhances reduction of body weight by chronic intracerebroventricular leptin infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868020-00002

Post-prandial decrease of circulating human ghrelin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868020-00002

Molecular forms of human enteroglucagon in tissue and plasma: plasma responses to nutrient stimuli in health and in disorders of the upper gastrointestinal tract

21 January 2018

1 reference

12 December 2020

Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion

1 reference

12 December 2020

Daily, intermittent intravenous infusion of peptide YY(3-36) reduces daily food intake and adiposity in rats

1 reference

12 December 2020

A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans

1 reference

12 December 2020

Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats

1 reference

12 December 2020

Amylin decreases meal size in rats

1 reference

12 December 2020

Immunohistochemical localization of human pancreatic polypeptide (HPP) to a population of islet cells

1 reference

12 December 2020

Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction

1 reference

12 December 2020

Satiety effects of cholecystokinin in humans

1 reference

12 December 2020

Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus.

1 reference

12 December 2020

Peripheral oxyntomodulin reduces food intake and body weight gain in rats.

1 reference

12 December 2020

Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty

1 reference

12 December 2020

Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice

1 reference

12 December 2020

Laparoscopic adjustable gastric band versus laparoscopic Roux-en-Y gastric bypass: ends justify the means?

1 reference

12 December 2020

Body composition, dietary intake, and energy expenditure after laparoscopic Roux-en-Y gastric bypass and laparoscopic vertical banded gastroplasty: a randomized clinical trial

1 reference

12 December 2020

Effects of selective CCK receptor agonists on food intake after central or peripheral administration in rats

1 reference

12 December 2020

Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety.

1 reference

12 December 2020

Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats.

1 reference

12 December 2020

A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice

1 reference

12 December 2020

Hamster preproglucagon contains the sequence of glucagon and two related peptides

1 reference

12 December 2020

Pancreatic polypeptide responses to protein meal challenges in obese but otherwise normal children and obese children with Prader-Willi syndrome

1 reference

12 December 2020

Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure

1 reference

12 December 2020

Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV

1 reference

12 December 2020

Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product

1 reference

12 December 2020

Ghrelin induces adiposity in rodents

1 reference

12 December 2020

Five weeks of treatment with the GLP-1 analogue liraglutide improves glycaemic control and lowers body weight in subjects with type 2 diabetes

1 reference

12 December 2020

Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: a phase 2, randomized, placebo-controlled, dose-escalation study

1 reference

12 December 2020

Loxiglumide, a CCK-A receptor antagonist, stimulates calorie intake and hunger feelings in humans

1 reference

12 December 2020

Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure

1 reference

12 December 2020

Effects of a physiological dose of cholecystokinin on food intake and postprandial satiation in man

1 reference

12 December 2020

Rapid development of tolerance to the behavioural actions of cholecystokinin

1 reference

12 December 2020

Effects of PYY[3-36] in rodent models of diabetes and obesity

1 reference

12 December 2020

Oxyntomodulin suppresses appetite and reduces food intake in humans

1 reference

12 December 2020

Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes

1 reference

12 December 2020

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

1 reference

12 December 2020

Ghrelin neutralization by a ribonucleic acid-SPM ameliorates obesity in diet-induced obese mice

1 reference

12 December 2020

Orexin neurons express a functional pancreatic polypeptide Y4 receptor.

1 reference

12 December 2020

Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV

1 reference

12 December 2020

Gut hormone PYY(3-36) physiologically inhibits food intake

1 reference

12 December 2020

Intracisternal injection of pancreatic polypeptide stimulates gastric emptying in rats

1 reference

12 December 2020

Pancreatic polypeptide stimulates gastric motility through a vagal-dependent mechanism in rats

1 reference

12 December 2020

Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1.

1 reference

12 December 2020

Ghrelin, leptin and insulin levels after restrictive surgery: a 2-year follow-up study.

1 reference

12 December 2020

Decreased food intake and body weight in pancreatic polypeptide-overexpressing mice

1 reference

12 December 2020

Neuropeptides in the gut: quantification and characterization of cholecystokinin octapeptide-, bombesin- and vasoactive intestinal polypeptide-like immunoreactivities in the myenteric plexus of the guinea-pig small institute.

1 reference

12 December 2020

Co-secretion of amylin and insulin from cultured islet β-cells: Modulation by nutrient secretagogues, islet hormones and hypoglycemic agents

1 reference

12 December 2020

Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36).

1 reference

12 December 2020

The decrease in plasma ghrelin concentrations following bariatric surgery depends on the functional integrity of the fundus

1 reference

12 December 2020

Ghrelin immunoreactivity in human plasma is suppressed by somatostatin

1 reference

12 December 2020

Peptide YY(3-36) inhibits morning, but not evening, food intake and decreases body weight in rhesus macaques

1 reference

12 December 2020

Inhibition of food intake in obese subjects by peptide YY3-36

1 reference

12 December 2020

The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight

1 reference

12 December 2020

Ghrelin increases food intake in obese as well as lean subjects

1 reference

12 December 2020

Expression cloning and receptor pharmacology of human calcitonin receptors from MCF-7 cells and their relationship to amylin receptors

1 reference

12 December 2020

Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study

1 reference

12 December 2020

Small-molecule agonists for the glucagon-like peptide 1 receptor

1 reference

12 December 2020

Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas

1 reference

12 December 2020

The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism

1 reference

12 December 2020

Inhibition of ghrelin action in vitro and in vivo by an RNA-Spiegelmer

1 reference

12 December 2020

The effect of oxyntomodulin (glucagon-37) and glucagon on exocrine pancreatic secretion in the conscious rat

1 reference

12 December 2020

Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes

1 reference

12 December 2020

A comparison of the effects of pegvisomant and octreotide on glucose, insulin, gastrin, cholecystokinin, and pancreatic polypeptide responses to oral glucose and a standard mixed meal

1 reference

12 December 2020

Active immunization against ghrelin decreases weight gain and alters plasma concentrations of growth hormone in growing pigs

1 reference

12 December 2020

Conformational flexibility in a small globular hormone: x-ray analysis of avian pancreatic polypeptide at 0.98-A resolution

1 reference

12 December 2020

Plasma concentrations of regulatory peptides in obesity following modified sham feeding (MSF) and a liquid test meal

1 reference

12 December 2020

Dipeptidyl peptidase IV substrates. An update on in vitro peptide hydrolysis by human DPPIV

1 reference

12 December 2020

Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial

1 reference

12 December 2020

PYY3-36 as an anti-obesity drug target.

1 reference

12 December 2020

Isolation of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. Characterization of the peptide

1 reference

12 December 2020

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

1 reference

12 December 2020

Ileal transposition surgery attenuates the increased efficiency of weight gain on a high-fat diet

1 reference

12 December 2020

Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial

1 reference

12 December 2020

Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients

1 reference

12 December 2020

Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans.

1 reference

12 December 2020

Laparoscopic adjustable gastric banding versus laparoscopic gastric bypass for morbid obesity: a single-institution comparison study of early results

1 reference

12 December 2020

A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis.

1 reference

12 December 2020

Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans

1 reference

12 December 2020

Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters

1 reference

12 December 2020

Influence of meal composition on postprandial peripheral plasma concentrations of vasoactive peptides in man

1 reference

12 December 2020

Oxyntomodulin-like immunoreactivity: diurnal profile of a new potential enterogastrone

1 reference

12 December 2020

A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes

1 reference

12 December 2020

Critical role for peptide YY in protein-mediated satiation and body-weight regulation

1 reference

12 December 2020

Antagonism of ghrelin receptor reduces food intake and body weight gain in mice

1 reference

12 December 2020

Effect of gastric bypass on spontaneous growth hormone and ghrelin release profiles

1 reference

12 December 2020

Efficacy and safety of intranasal peptide YY3-36 for weight reduction in obese adults

1 reference

12 December 2020

Capsaicin pretreatment attenuates suppression of food intake by cholecystokinin

1 reference

12 December 2020

Ileal enteroglucagon cells after ileal-duodenal transposition in the rat

1 reference

12 December 2020

Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome.

1 reference

12 December 2020

Fasting and postprandial plasma pancreatic polypeptide (PP) levels in obesity

1 reference

12 December 2020

Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats

1 reference

12 December 2020

Changes in eating behavior after horizontal gastroplasty and Roux-en-Y gastric bypass

1 reference

12 December 2020

Effect of peptide YY3-36 on food intake in humans

1 reference

12 December 2020

Mechanisms of peptide YY release induced by an intraduodenal meal in rats: neural regulation by proximal gut

1 reference

12 December 2020

C-terminal octapeptide of cholecystokinin decreases food intake in man.

1 reference

12 December 2020

Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice

1 reference

12 December 2020

Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial

1 reference

12 December 2020

Regional distributions of somatostatin and cholecystokinin-like immunoreactivities in rat and bovine brain

1 reference

12 December 2020

‘Enteroglucagon’: A specific effect on gastric glands isolated from the rat fundus. Evidence for an ‘oxyntomodulin’ action

1 reference

12 December 2020

Satiety effects of a physiological dose of cholecystokinin in humans

1 reference

12 December 2020

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study

1 reference

12 December 2020

Food fails to suppress ghrelin levels in obese humans.

1 reference

12 December 2020

Impact of laparoscopic adjustable gastric banding on plasma ghrelin, eating behaviour and body weight

1 reference

12 December 2020

Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects

1 reference

12 December 2020

Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans.

1 reference

12 December 2020

Laparoscopic bariatric surgery in super-obese patients (BMI>50) is safe and effective: a review of 332 patients

1 reference

12 December 2020

Oxyntomodulin (glucagon-37 or bioactive enteroglucagon): a potent inhibitor of pentagastrin-stimulated acid secretion in rats

1 reference

12 December 2020

Dose-responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7-36) NH2, amylin, cholecystokinin, and other possible regulators of nutrient uptake

1 reference

12 December 2020

Selective amylin inhibition of the glucagon response to arginine is extrinsic to the pancreas

1 reference

12 December 2020

Weight loss and dietary intake after vertical banded gastroplasty and Roux-en-Y gastric bypass

1 reference

12 December 2020

Fasting- and meal-stimulated peptide hormone concentrations before and after gastric surgery for morbid obesity.

1 reference

12 December 2020

Effect of jejunoileal bypass operation and Billroth II resection on postprandial plasma pancreatic polypeptide release

1 reference

12 December 2020

Cholecystokinin and leptin act synergistically to reduce body weight

1 reference

12 December 2020

Feeding response to ghrelin agonist and antagonist in lean and obese Zucker rats

1 reference

12 December 2020

Circulating ghrelin levels are decreased in human obesity.

1 reference

12 December 2020

Human gut hormone profiles in patients with short bowel syndrome

1 reference

12 December 2020

A novel growth hormone secretagogue-1a receptor antagonist that blocks ghrelin-induced growth hormone secretion but induces increased body weight gain

1 reference

12 December 2020

Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing

1 reference

12 December 2020

Amylin: a novel action in the brain to reduce body weight

1 reference

12 December 2020

Plasma and cerebroventricular fluid levels of pancreatic polypeptide in the dog: effects of feeding, insulin-induced hypoglycemia, and physical exercise

1 reference

12 December 2020

Glucagon-like peptide-1 7-36: a physiological incretin in man.

1 reference

12 December 2020

Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy

1 reference

12 December 2020

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

1 reference

12 December 2020

Distribution and release of human pancreatic polypeptide

1 reference

12 December 2020

A role for pancreatic polypeptide in the regulation of gastric emptying and short-term metabolic control

1 reference

12 December 2020

Acute 3rd-ventricular amylin infusion potently reduces food intake but does not produce aversive consequences

1 reference

12 December 2020

Differential hypothalamic neuronal activation following peripheral injection of GLP-1 and oxyntomodulin in mice detected by manganese-enhanced magnetic resonance imaging

1 reference

12 December 2020

Physiology: does gut hormone PYY3-36 decrease food intake in rodents?

1 reference

12 December 2020

Characterization of saturable binding sites for circulating pancreatic polypeptide in rat brain.

1 reference

12 December 2020

Glucagonlike peptide I (7-37) actions on endocrine pancreas

1 reference

12 December 2020

Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides

1 reference

12 December 2020

Vagal afferent and efferent contributions to the inhibition of food intake by cholecystokinin

1 reference

12 December 2020

Anti-ghrelin Spiegelmer NOX-B11 inhibits neurostimulatory and orexigenic effects of peripheral ghrelin in rats

1 reference

12 December 2020

Randomized clinical trial of laparoscopic Roux-en-Y gastric bypass versus laparoscopic vertical banded gastroplasty for obesity

1 reference

12 December 2020

Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats

1 reference

12 December 2020

Overweight and obesity mortality trends in Canada, 1985-2000.

1 reference

12 December 2020

Identification of cholecystokinin-secreting cells

1 reference

12 December 2020

Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively

1 reference

12 December 2020

Increased cholecystokinin and pancreatic polypeptide responses to a fat-rich meal in patients with restrictive but not bulimic anorexia nervosa

1 reference

12 December 2020

Obesity as a medical problem

1 reference

12 December 2020

C-Terminal octapeptide of cholecystokinin decreases food intake in obese men☆☆☆

1 reference

12 December 2020

Effects of ileal transposition on food intake, dietary preference, and weight gain in Zucker obese rats

1 reference

12 December 2020

Laparoscopic adjustable gastric banding induces prolonged satiety: a randomized blind crossover study

1 reference

12 December 2020

Control of body weight by lower gut signals

1 reference

12 December 2020

Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion

1 reference

12 December 2020

Proglucagon processing in islet and intestinal cell lines

1 reference

12 December 2020

Ghrelin enhances appetite and increases food intake in humans

1 reference

12 December 2020

Biological effects and metabolic rates of glucagonlike peptide-1 7-36 amide and glucagonlike peptide-1 7-37 in healthy subjects are indistinguishable

1 reference

12 December 2020

Long-term effects of exenatide therapy over 82 weeks on glycaemic control and weight in over-weight metformin-treated patients with type 2 diabetes mellitus

1 reference

12 December 2020

The effects of ileal transposition and jejunoileal bypass on food intake and GI hormone levels in rats

1 reference

12 December 2020

Cholecystokinin persistently suppresses meal size but not food intake in free-feeding rats

1 reference

12 December 2020

Abrogation of peripheral cholecystokinin-satiety in the capsaicin treated rat.

1 reference

12 December 2020

Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients.

1 reference

12 December 2020

Pre-obese and obese agouti mice are sensitive to the anorectic effects of peptide YY(3-36) but resistant to ghrelin

1 reference

12 December 2020

A case-controlled matched-pair cohort study of laparoscopic Roux-en-Y gastric bypass and Lap-Band patients in a single US center with three-year follow-up

1 reference

12 December 2020

Effects of liraglutide (NN2211), a long-acting GLP-1 analogue, on glycaemic control and bodyweight in subjects with Type 2 diabetes

1 reference

12 December 2020

Cholecystokinin decreases food intake in rats.

1 reference

12 December 2020

The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion

1 reference

12 December 2020

Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes

1 reference

12 December 2020

Exon duplication and divergence in the human preproglucagon gene

1 reference

12 December 2020

Loss of meal-induced decrease in plasma ghrelin levels in patients with anorexia nervosa.

1 reference

12 December 2020

Divergent trends in the incidence of end-stage renal disease due to Type 1 and Type 2 diabetes in Europe, Canada and Australia during 1998-2002.

1 reference

12 December 2020

Effects of dipeptidyl peptidase IV on the satiety actions of peptide YY

1 reference

12 December 2020

High constitutive signaling of the ghrelin receptor--identification of a potent inverse agonist

1 reference

12 December 2020

Oxyntomodulin from distal gut. Role in regulation of gastric and pancreatic functions.

1 reference

12 December 2020

Distribution of pancreatic polypeptide and peptide YY

1 reference

12 December 2020

Amylin potently activates AP neurons possibly via formation of the excitatory second messenger cGMP.

1 reference

12 December 2020

Vertical banded gastroplasty modifies plasma ghrelin secretion in obese patients

1 reference

12 December 2020

Ghrelin causes hyperphagia and obesity in rats.

1 reference

12 December 2020

Oxyntomodulin inhibits food intake in the rat

1 reference

12 December 2020

Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus

1 reference

12 December 2020

Blunted pancreatic polypeptide responses in children with obesity of Prader-Willi syndrome

1 reference

12 December 2020

Somatostatin infusion lowers plasma ghrelin without reducing appetite in adults with Prader-Willi syndrome

1 reference

12 December 2020

Laparoscopic gastric bypass versus laparoscopic adjustable gastric banding in the super-obese: a comparative study of 290 patients

1 reference

12 December 2020

Cholecystokinin and gastrin receptors

1 reference

12 December 2020

A role for glucagon-like peptide-1 in the central regulation of feeding

1 reference

12 December 2020

The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats

1 reference

12 December 2020

Pancreatic polypeptide infusions reduce food intake in Prader-Willi syndrome

1 reference

12 December 2020

Acute effects of PYY3-36 on food intake and hypothalamic neuropeptide expression in the mouse.

1 reference

12 December 2020

Estimated burden of paediatric obesity and co-morbidities in Europe. Part 2. Numbers of children with indicators of obesity-related disease.

1 reference

12 December 2020

Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men.

1 reference

12 December 2020

PYY[3-36] administration decreases the respiratory quotient and reduces adiposity in diet-induced obese mice

1 reference

12 December 2020

RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor

1 reference

12 December 2020

A double-blind, placebo-controlled trial assessing pramlintide treatment in the setting of intensive insulin therapy in type 1 diabetes.

1 reference

12 December 2020

Effects of peripheral administration of PYY3-36 on feed intake and plasma acyl-ghrelin levels in pigs.

1 reference

12 December 2020

Attenuated peptide YY release in obese subjects is associated with reduced satiety.

1 reference

12 December 2020

Gut vagal afferents are not necessary for the eating-stimulatory effect of intraperitoneally injected ghrelin in the rat

1 reference

12 December 2020

Lower mean weight after 14 days intravenous administration peptide YY3-36 (PYY3-36) in rabbits

1 reference

12 December 2020

Pancreatic Polypeptide Response to Secretin in Obesity: Effects of Glucose Intolerance

1 reference

12 December 2020

Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass

1 reference

12 December 2020

Effect of gastric distension prior to eating on food intake and feelings of satiety in humans

1 reference

12 December 2020

Exenatide elicits sustained glycaemic control and progressive reduction of body weight in patients with type 2 diabetes inadequately controlled by sulphonylureas with or without metformin

1 reference

12 December 2020

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans

1 reference

12 December 2020

Appetitive behavior after gastric bypass for obesity

1 reference

12 December 2020

The predominant cholecystokinin in human plasma and intestine is cholecystokinin-33.

1 reference

12 December 2020

Pancreatic polypeptide reduces appetite and food intake in humans

1 reference

12 December 2020

Characterization of the effects of pancreatic polypeptide in the regulation of energy balance

1 reference

12 December 2020

Pharmacotherapy for obesity

1 reference

12 December 2020

Short-term effects of gastric bypass surgery on circulating ghrelin levels.

1 reference

12 December 2020

Worldwide trends in childhood overweight and obesity.

1 reference

12 December 2020

Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial

1 reference

12 December 2020

Plasma cholecystokinin and pancreatic polypeptide secretion in response to bombesin, meal ingestion and modified sham feeding in lean and obese persons

1 reference

12 December 2020

Potential regulators of feeding behavior In anorexia nervosa

1 reference

12 December 2020

Mouse pancreatic polypeptide modulates food intake, while not influencing anxiety in mice.

1 reference

12 December 2020

Prevalence and Trends in Obesity Among US Adults, 1999-2000

1 reference

12 December 2020

Effect of human body weight changes on circulating levels of peptide YY and peptide YY3-36.

1 reference

12 December 2020

A role for ghrelin in the central regulation of feeding

1 reference

12 December 2020

Plasma ghrelin levels and hunger scores in humans initiating meals voluntarily without time- and food-related cues

1 reference

12 December 2020

Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects.

1 reference

12 December 2020

A new molecular form of PYY: structural characterization of human PYY(3-36) and PYY(1-36)

1 reference

12 December 2020

Novel analogs of ghrelin: physiological and clinical implications

1 reference

12 December 2020

Laparoscopic gastric bypass is superior to laparoscopic gastric banding for treatment of morbid obesity

1 reference

12 December 2020

Vaccination against weight gain

1 reference

12 December 2020

Laparoscopic gastric bypass is superior to adjustable gastric band in super morbidly obese patients: A prospective, comparative analysis.

1 reference

12 December 2020

The neuropeptide Y (Y4) receptor is highly expressed in neurones of the rat dorsal vagal complex

1 reference

12 December 2020

High circulating ghrelin: a potential cause for hyperphagia and obesity in prader-willi syndrome

1 reference

12 December 2020

The effects of ileal transposition on food intake and body weight loss in VMH-obese rats

1 reference

12 December 2020

Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea

1 reference

12 December 2020

The management and control of hospital-acquired infection in acute NHS trusts in England: a report by the Comptroller and Auditor General--the who, how and what

1 reference

12 December 2020

Recent developments in our understanding of the physiological role of PP-fold peptide receptor subtypes.

1 reference

12 December 2020

Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake

1 reference

12 December 2020

Low plasma levels of pancreatic polypeptide in obesity.

1 reference

12 December 2020

Early U.S. outcomes of laparoscopic gastric bypass versus laparoscopic adjustable silicone gastric banding for morbid obesity

1 reference

12 December 2020

10.2165/00003495-200868020-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

18 August 2017

1028739692

0 references

1 reference